These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8931385)

  • 1. Reduction of intracellular pH is not the mechanism for the synergistic interaction between photodynamic therapy and nigericin.
    Varnes ME; Bayne MT; Bright GR
    Photochem Photobiol; 1996 Nov; 64(5):853-8. PubMed ID: 8931385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the K+/H+ ionophore nigericin on response of A549 cells to photodynamic therapy and tert-butylhydroperoxide.
    Varnes ME; Bayne MT; Menegay HJ; Tuttle SW
    Free Radic Biol Med; 1993 Oct; 15(4):395-405. PubMed ID: 8225021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of photodynamic cell killing (with chloroaluminum phthalocyanine) by treatment of V79 cells with the ionophore nigericin.
    Varnes ME; Clay ME; Freeman K; Antunez AR; Oleinick NL
    Cancer Res; 1990 Mar; 50(5):1620-5. PubMed ID: 2302719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nigericin enhances mafosfamide cytotoxicity at low extracellular pH.
    Jähde E; Glüsenkamp KH; Rajewsky MF
    Cancer Chemother Pharmacol; 1991; 27(6):440-4. PubMed ID: 2013114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. pH-dependent effects of the ionophore nigericin on response of mammalian cells to radiation and heat treatment.
    Varnes ME; Glazier KG; Gray C
    Radiat Res; 1989 Feb; 117(2):282-92. PubMed ID: 2922473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modification of intracellular pH and thermosensitivity.
    Lyons JC; Kim GE; Song CW
    Radiat Res; 1992 Jan; 129(1):79-87. PubMed ID: 1728060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor activity of nigericin and 5-(N-ethyl-N-isopropyl)amiloride: an approach to therapy based on cellular acidification and the inhibition of regulation of intracellular pH.
    Hasuda K; Lee C; Tannock IF
    Oncol Res; 1994; 6(6):259-68. PubMed ID: 7865901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevation of GRP-78 and loss of HSP-70 following photodynamic treatment of V79 cells: sensitization by nigericin.
    Xue LY; Agarwal ML; Varnes ME
    Photochem Photobiol; 1995 Jul; 62(1):135-43. PubMed ID: 7638257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of agents which inhibit the regulation of intracellular pH on murine solid tumours.
    Newell K; Wood P; Stratford I; Tannock I
    Br J Cancer; 1992 Aug; 66(2):311-7. PubMed ID: 1503904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The chronic administration of drugs that inhibit the regulation of intracellular pH: in vitro and anti-tumour effects.
    Yamagata M; Tannock IF
    Br J Cancer; 1996 Jun; 73(11):1328-34. PubMed ID: 8645575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxicity of compounds that interfere with the regulation of intracellular pH: a potential new class of anticancer drugs.
    Rotin D; Wan P; Grinstein S; Tannock I
    Cancer Res; 1987 Mar; 47(6):1497-504. PubMed ID: 3815351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of recovery from potentially lethal radiation damage in A549 cells by the K+/H+ ionophore nigericin.
    Varnes ME; Menegay HJ; McKenna DS
    Int J Radiat Oncol Biol Phys; 1991 Feb; 20(2):281-5. PubMed ID: 1991689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of intracellular pH as a possible mechanism for killing cells in acidic regions of solid tumors: effects of carbonylcyanide-3-chlorophenylhydrazone.
    Newell KJ; Tannock IF
    Cancer Res; 1989 Aug; 49(16):4477-82. PubMed ID: 2743336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of the regulation of intracellular pH: potential of 5-(N,N-hexamethylene) amiloride in tumour-selective therapy.
    Luo J; Tannock IF
    Br J Cancer; 1994 Oct; 70(4):617-24. PubMed ID: 7917906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acridine orange used for photodynamic therapy accumulates in malignant musculoskeletal tumors depending on pH gradient.
    Matsubara T; Kusuzaki K; Matsumine A; Shintani K; Satonaka H; Uchida A
    Anticancer Res; 2006; 26(1A):187-93. PubMed ID: 16475697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic potential of analogues of amiloride: inhibition of the regulation of intracellular pH as a possible mechanism of tumour selective therapy.
    Maidorn RP; Cragoe EJ; Tannock IF
    Br J Cancer; 1993 Feb; 67(2):297-303. PubMed ID: 8381657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the synergistic anticancer activity of AlPcS4 photodynamic therapy in combination with different low‑dose chemotherapeutic agents on gastric cancer cells.
    Xin J; Wang S; Zhang L; Xin B; He Y; Wang J; Wang S; Shen L; Zhang Z; Yao C
    Oncol Rep; 2018 Jul; 40(1):165-178. PubMed ID: 29767247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different pH dependency of mitomycin C activity in monolayer and three-dimensional cultures.
    Yen WC; Schmittgen T; Au JL
    Pharm Res; 1996 Dec; 13(12):1887-91. PubMed ID: 8987090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of intracellular pH and blood flow in rat duodenal epithelium in vivo.
    Akiba Y; Kaunitz JD
    Am J Physiol; 1999 Jan; 276(1):G293-302. PubMed ID: 9887007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inadequacy of high K+/nigericin for calibrating BCECF. II. Intracellular pH dependence of the correction.
    Boyarsky G; Hanssen C; Clyne LA
    Am J Physiol; 1996 Oct; 271(4 Pt 1):C1146-56. PubMed ID: 8897820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.